The NIH Common Fund PRIMED-AI Model-to-Clinic (M2C) 2026 program supports the translation of multimodal artificial intelligence models into clinically useful tools for precision medicine.
The initiative focuses on advancing AI models that integrate medical imaging with additional health data toward clinical validation, implementation, and future adoption in healthcare settings.
Eligibility Criteria
- Eligible applicants include U.S. and international research institutions that meet NIH requirements.
- Applications must include multidisciplinary expertise in AI, clinical research, and precision medicine.
- Projects must focus on clinically relevant AI model translation.
- Research should involve multimodal data with medical imaging as a key component.
- Collaborative academic and industry partnerships are encouraged.
Funding Details
- Funding mechanism: UG3/UH3 Cooperative Agreement
- Duration: Up to 5 years
- Funding supports development, validation, and clinical translation of AI-based precision medicine approaches.
Deadline
- Application deadline: October 19, 2026
- Funding opportunity number: RFA-RM-27-013
Further Information
- Research areas may include AI-driven decision support, imaging analysis, multimodal data integration, and precision medicine.
- Successful applicants will participate in the PRIMED-AI consortium.
- Applications are submitted through the NIH grant application system.
- Official NIH PRIMED-AI Funding Opportunities